- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.65 Å
- Oligo State
- hetero-1-1-1-1-1-1-1-1-1-1-1-1-1-mer
- Ligands
- 2 x HEA: HEME-A(Non-covalent)
- 1 x CU: COPPER (II) ION(Non-covalent)
- 1 x MG: MAGNESIUM ION(Non-covalent)
- 1 x NA: SODIUM ION(Non-functional Binders)
- 1 x CYN: CYANIDE ION(Non-covalent)
- 3 x TGL: TRISTEAROYLGLYCEROL(Non-covalent)
TGL.7: 24 residues within 4Å:- Chain A: F.2, T.17, L.18, L.20, L.21, F.22, W.25, P.106, L.110, L.113, F.393, F.400, S.401, I.472
- Chain L: N.9, I.10, P.11, F.12, S.13, R.19, M.24, F.27, F.28
- Ligands: HEA.1
20 PLIP interactions:12 interactions with chain A, 8 interactions with chain L- Hydrophobic interactions: A:F.2, A:F.2, A:F.2, A:L.18, A:L.20, A:F.22, A:W.25, A:W.25, A:W.25, A:L.113, A:F.400, A:I.472, L:I.10, L:F.12, L:F.12, L:F.12, L:F.27, L:F.27, L:F.28, L:F.28
TGL.27: 17 residues within 4Å:- Chain A: F.346, V.350, T.354, N.422, F.426, H.429, F.430, L.433
- Chain B: L.7, G.8, L.28, V.31, F.32, S.35, S.36, L.39
- Chain I: R.43
21 PLIP interactions:9 interactions with chain B, 11 interactions with chain A, 1 interactions with chain I- Hydrophobic interactions: B:L.7, B:L.28, B:V.31, B:F.32, B:F.32, B:F.32, B:L.39, A:F.346, A:F.346, A:V.350, A:T.354, A:F.426, A:F.426, A:F.426, A:F.426, A:H.429, A:F.430, A:F.430
- Water bridges: B:G.8
- Salt bridges: B:H.24, I:R.43
TGL.52: 20 residues within 4Å:- Chain A: W.334, M.339, L.342, G.343, K.411, F.414, A.415, V.419
- Chain B: L.39, I.42, T.47, K.49
- Chain D: R.70, S.71, T.72, E.74, W.75, V.78, M.83, I.86
17 PLIP interactions:6 interactions with chain D, 8 interactions with chain A, 3 interactions with chain B- Hydrophobic interactions: D:W.75, D:V.78, D:I.86, A:W.334, A:W.334, A:W.334, A:L.342, A:F.414, A:A.415, A:V.419, B:L.39, B:I.42, B:K.49
- Hydrogen bonds: D:E.74, D:W.75
- Water bridges: D:T.72
- Salt bridges: A:K.411
- 4 x PGV: (1R)-2-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PALMITOYLOXY)METHYL]ETHYL (11E)-OCTADEC-11-ENOATE(Non-covalent)
PGV.8: 12 residues within 4Å:- Chain A: N.406, T.408, W.409
- Chain D: T.77, A.81, F.84
- Chain K: F.4, H.5
- Chain M: P.12, Q.15, A.16
- Ligands: EDO.82
12 PLIP interactions:4 interactions with chain D, 5 interactions with chain A, 3 interactions with chain K- Hydrophobic interactions: D:T.77, D:A.81, D:F.84, D:F.84, A:T.408, A:W.409, A:W.409, A:W.409, K:F.4, K:F.4
- Hydrogen bonds: A:T.408
- Salt bridges: K:H.5
PGV.9: 29 residues within 4Å:- Chain A: F.94, P.95, R.96, M.97, F.148, H.151, L.152, V.155, I.158
- Chain C: H.7, V.9, G.18, A.22, T.26, N.48, T.51, M.52, W.55, W.56, V.59, E.62, H.69, L.77, G.80, F.84, S.87, E.88
- Ligands: PGV.39, PEK.63
16 PLIP interactions:8 interactions with chain A, 8 interactions with chain C- Hydrophobic interactions: A:F.148, A:L.152, A:V.155, A:I.158, C:A.22, C:T.26, C:T.51, C:W.55, C:W.55, C:W.55, C:W.56
- Hydrogen bonds: A:R.96, A:R.96, A:M.97, C:W.55
- Salt bridges: A:R.96
PGV.39: 24 residues within 4Å:- Chain C: N.48, M.52, W.56, V.59, I.60, S.63, T.64, H.69, L.77, F.84, E.88, H.205, I.208, T.211, F.212, R.219, H.224, F.225, T.226, H.229, H.230, F.231, G.232
- Ligands: PGV.9
27 PLIP interactions:25 interactions with chain C, 2 interactions with chain F- Hydrophobic interactions: C:W.56, C:W.56, C:W.56, C:W.56, C:W.56, C:I.60, C:F.84, C:F.84, C:I.208, C:I.208, C:T.211, C:F.212, C:F.212, C:F.212
- Hydrogen bonds: C:S.63, C:R.219, C:F.231, C:G.232
- Water bridges: C:S.63, C:R.219, C:H.229, C:H.229, F:Q.12, F:E.17
- Salt bridges: C:R.219, C:R.219, C:H.229
PGV.40: 11 residues within 4Å:- Chain A: F.237
- Chain C: T.93, W.97, Y.100, H.101, L.104, A.105
- Chain H: N.16, N.18
- Ligands: EDO.26, CHD.37
11 PLIP interactions:6 interactions with chain H, 4 interactions with chain C, 1 interactions with chain A- Hydrogen bonds: H:N.16
- Water bridges: H:N.16, H:N.18, H:N.18, H:N.18, H:N.18
- Hydrophobic interactions: C:W.97, C:W.97, C:W.97, A:F.237
- Salt bridges: C:H.101
- 48 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.10: 8 residues within 4Å:- Chain A: V.56, T.59, A.60, L.112, S.115, S.116, G.121, A.122
Ligand excluded by PLIPEDO.11: 8 residues within 4Å:- Chain A: G.269, Y.270, M.271, G.272
- Chain B: A.58, Q.59, E.62
- Ligands: CHD.30
Ligand excluded by PLIPEDO.12: 4 residues within 4Å:- Chain A: K.265, T.489
- Chain F: I.70, S.84
Ligand excluded by PLIPEDO.13: 7 residues within 4Å:- Chain A: Y.260, Y.261, V.394, H.395, P.398, W.494
- Chain M: I.1
Ligand excluded by PLIPEDO.14: 5 residues within 4Å:- Chain A: W.334, S.335, P.336, D.407, K.411
Ligand excluded by PLIPEDO.15: 7 residues within 4Å:- Chain A: P.182, H.256, T.259, K.265, T.490, N.491
- Ligands: EDO.59
Ligand excluded by PLIPEDO.16: 6 residues within 4Å:- Chain A: Q.52, A.120, A.137, H.138, A.139
- Ligands: EDO.20
Ligand excluded by PLIPEDO.17: 9 residues within 4Å:- Chain A: P.444, D.445, A.446
- Chain B: M.1, A.2, P.4, L.133
- Chain D: Q.116, M.120
Ligand excluded by PLIPEDO.18: 5 residues within 4Å:- Chain A: P.131, D.221, P.222
- Ligands: EDO.19, EDO.33
Ligand excluded by PLIPEDO.19: 7 residues within 4Å:- Chain A: D.221, P.222, A.223
- Ligands: EDO.18, EDO.32, EDO.33, EDO.43
Ligand excluded by PLIPEDO.20: 5 residues within 4Å:- Chain A: L.136, A.137
- Chain B: Q.103, W.104
- Ligands: EDO.16
Ligand excluded by PLIPEDO.21: 9 residues within 4Å:- Chain A: R.5, N.11, K.13, D.14, W.81, P.499, P.500, Y.502
- Chain L: N.9
Ligand excluded by PLIPEDO.22: 6 residues within 4Å:- Chain A: K.333, T.484, D.486
- Chain M: I.1, T.2
- Ligands: EDO.55
Ligand excluded by PLIPEDO.23: 8 residues within 4Å:- Chain A: E.507
- Chain C: T.3
- Chain F: P.30, N.32, P.50, S.51, R.56, H.94
Ligand excluded by PLIPEDO.24: 3 residues within 4Å:- Chain A: Y.502
- Chain C: P.11
- Chain L: Y.2
Ligand excluded by PLIPEDO.25: 5 residues within 4Å:- Chain A: D.50, D.51
- Chain B: S.202, N.203, F.206
Ligand excluded by PLIPEDO.26: 3 residues within 4Å:- Chain A: Y.304
- Ligands: CHD.37, PGV.40
Ligand excluded by PLIPEDO.31: 7 residues within 4Å:- Chain A: Y.447
- Chain B: M.1, A.2, Q.10, L.136, P.166, Y.193
Ligand excluded by PLIPEDO.32: 5 residues within 4Å:- Chain B: E.157, P.176
- Ligands: EDO.19, EDO.33, EDO.43
Ligand excluded by PLIPEDO.33: 6 residues within 4Å:- Chain A: L.136
- Chain B: D.158, V.159
- Ligands: EDO.18, EDO.19, EDO.32
Ligand excluded by PLIPEDO.34: 3 residues within 4Å:- Chain B: H.102, E.157, D.158
Ligand excluded by PLIPEDO.35: 7 residues within 4Å:- Chain B: S.14, P.15, I.16, L.168, T.183, L.184, M.185
Ligand excluded by PLIPEDO.36: 3 residues within 4Å:- Chain B: T.66, I.67
- Ligands: CHD.30
Ligand excluded by PLIPEDO.43: 7 residues within 4Å:- Chain A: P.222
- Chain B: G.177
- Chain C: E.109
- Chain H: W.62
- Ligands: EDO.19, EDO.32, EDO.45
Ligand excluded by PLIPEDO.44: 3 residues within 4Å:- Chain C: W.256, W.257
- Ligands: EDO.50
Ligand excluded by PLIPEDO.45: 5 residues within 4Å:- Chain B: G.177
- Chain C: E.109
- Chain H: W.62, W.66
- Ligands: EDO.43
Ligand excluded by PLIPEDO.46: 7 residues within 4Å:- Chain C: W.144, S.148, H.156
- Chain F: A.1
- Chain G: A.13, R.14, R.17
Ligand excluded by PLIPEDO.47: 6 residues within 4Å:- Chain C: Y.53, R.57
- Chain J: T.27, D.28, L.31
- Ligands: CDL.41
Ligand excluded by PLIPEDO.48: 1 residues within 4Å:- Chain C: V.245
Ligand excluded by PLIPEDO.49: 2 residues within 4Å:- Chain C: F.249
- Ligands: CDL.64
Ligand excluded by PLIPEDO.50: 2 residues within 4Å:- Chain C: W.257
- Ligands: EDO.44
Ligand excluded by PLIPEDO.53: 6 residues within 4Å:- Chain D: K.118, L.121, D.122, W.135, N.140
- Chain K: P.45
Ligand excluded by PLIPEDO.54: 3 residues within 4Å:- Chain D: P.103, I.104
- Chain K: G.32
Ligand excluded by PLIPEDO.55: 6 residues within 4Å:- Chain A: T.484, V.485, D.486
- Chain D: S.12, V.14
- Ligands: EDO.22
Ligand excluded by PLIPEDO.56: 3 residues within 4Å:- Chain E: Y.14, K.17, E.24
Ligand excluded by PLIPEDO.57: 2 residues within 4Å:- Chain E: R.49, R.53
Ligand excluded by PLIPEDO.59: 7 residues within 4Å:- Chain A: T.489, T.490
- Chain F: S.67, T.68, V.69, W.71
- Ligands: EDO.15
Ligand excluded by PLIPEDO.60: 6 residues within 4Å:- Chain A: Y.510
- Chain F: P.36, K.37, T.39, N.47, L.48
Ligand excluded by PLIPEDO.61: 6 residues within 4Å:- Chain A: K.265, E.266
- Chain B: T.55
- Chain F: N.66, T.68, S.84
Ligand excluded by PLIPEDO.62: 4 residues within 4Å:- Chain C: N.228, H.229
- Chain F: D.9, E.17
Ligand excluded by PLIPEDO.65: 6 residues within 4Å:- Chain C: G.118
- Chain G: A.46, F.47, I.48, L.53, R.54
Ligand excluded by PLIPEDO.66: 2 residues within 4Å:- Chain G: A.1, A.3
Ligand excluded by PLIPEDO.68: 6 residues within 4Å:- Chain B: S.94, L.95, Y.113, M.148, F.219
- Chain H: Q.6
Ligand excluded by PLIPEDO.72: 4 residues within 4Å:- Chain J: A.6, Q.9, K.10, Q.13
Ligand excluded by PLIPEDO.76: 3 residues within 4Å:- Chain L: S.30, F.37
- Ligands: DMU.79
Ligand excluded by PLIPEDO.77: 5 residues within 4Å:- Chain A: M.1, F.2, R.5
- Chain L: Y.2, E.3
Ligand excluded by PLIPEDO.81: 6 residues within 4Å:- Chain A: T.46, L.47
- Chain D: V.100
- Chain M: L.37, D.38, K.41
Ligand excluded by PLIPEDO.82: 5 residues within 4Å:- Chain A: T.404, D.407
- Chain M: I.1, A.3
- Ligands: PGV.8
Ligand excluded by PLIP- 1 x CUA: DINUCLEAR COPPER ION(Non-covalent)
- 1 x PSC: (7R,17E,20E)-4-HYDROXY-N,N,N-TRIMETHYL-9-OXO-7-[(PALMITOYLOXY)METHYL]-3,5,8-TRIOXA-4-PHOSPHAHEXACOSA-17,20-DIEN-1-AMINIUM 4-OXIDE(Non-covalent)
PSC.29: 19 residues within 4Å:- Chain A: F.321, L.324, H.328
- Chain B: I.41, M.45, H.52, M.56, D.57, E.60, V.61, I.64, W.65, P.69, I.72
- Chain E: E.2, F.7
- Chain I: R.10, A.14, L.17
12 PLIP interactions:6 interactions with chain B, 2 interactions with chain E, 4 interactions with chain A- Hydrophobic interactions: B:I.41, B:M.56, B:I.64, B:W.65, B:P.69, B:I.72, A:F.321, A:F.321, A:L.324, A:H.328
- Hydrogen bonds: E:E.2, E:D.4
- 5 x CHD: CHOLIC ACID(Non-covalent)
CHD.30: 9 residues within 4Å:- Chain A: M.271, G.272, W.275
- Chain B: Q.59, E.62, T.63, T.66
- Ligands: EDO.11, EDO.36
7 PLIP interactions:4 interactions with chain A, 3 interactions with chain B- Hydrophobic interactions: A:M.271, A:W.275, A:W.275, A:W.275, B:T.66
- Hydrogen bonds: B:Q.59, B:E.62
CHD.37: 9 residues within 4Å:- Chain A: H.233, W.288, D.300, T.301, Y.304
- Chain C: W.97, H.101
- Ligands: EDO.26, PGV.40
10 PLIP interactions:7 interactions with chain A, 3 interactions with chain C- Hydrophobic interactions: A:W.288, A:Y.304, C:W.97
- Hydrogen bonds: A:T.301, C:W.97
- Water bridges: A:D.298, A:D.300, A:T.301
- Salt bridges: A:H.233, C:H.101
CHD.42: 5 residues within 4Å:- Chain C: R.154, F.162, F.217, L.221
- Chain J: F.1
7 PLIP interactions:6 interactions with chain C, 1 interactions with chain J- Hydrophobic interactions: C:F.162, C:F.162, C:F.162, C:F.217, C:L.221
- Salt bridges: C:R.154
- Hydrogen bonds: J:F.1
CHD.71: 6 residues within 4Å:- Chain A: I.3
- Chain J: Y.32, R.33, M.36, T.37, L.40
6 PLIP interactions:5 interactions with chain J, 1 interactions with chain A- Hydrophobic interactions: J:Y.32, J:R.33, J:M.36, A:I.3
- Hydrogen bonds: J:R.33, J:R.33
CHD.78: 5 residues within 4Å:- Chain L: W.18, A.22
- Chain M: E.14, I.17, V.21
6 PLIP interactions:3 interactions with chain M, 3 interactions with chain L- Hydrophobic interactions: M:V.21, M:V.21, L:W.18, L:W.18, L:W.18
- Hydrogen bonds: M:E.14
- 2 x PEK: (1S)-2-{[(2-AMINOETHOXY)(HYDROXY)PHOSPHORYL]OXY}-1-[(STEAROYLOXY)METHYL]ETHYL (5E,8E,11E,14E)-ICOSA-5,8,11,14-TETRAENOATE(Non-covalent)
PEK.38: 11 residues within 4Å:- Chain C: K.155, H.156, Q.159, T.166, Y.170
- Chain F: A.1
- Chain G: R.17, F.21, G.22, L.23
- Ligands: CDL.64
8 PLIP interactions:3 interactions with chain G, 5 interactions with chain C- Hydrophobic interactions: G:F.21, G:L.23, C:Y.170, C:Y.170
- Salt bridges: G:R.17
- Hydrogen bonds: C:K.155, C:K.155
- Water bridges: C:Q.159
PEK.63: 21 residues within 4Å:- Chain A: H.151, L.210, L.215
- Chain C: W.32, Y.179, Y.180, A.182, F.184, T.185, I.186, F.196, G.200, F.201
- Chain G: W.62, T.68, F.69, F.70, H.71, N.76
- Ligands: PGV.9, DMU.67
16 PLIP interactions:10 interactions with chain G, 4 interactions with chain C, 2 interactions with chain A- Hydrophobic interactions: G:W.62, G:F.69, G:F.70, C:W.32, C:I.186, C:F.201, A:L.210, A:L.215
- Hydrogen bonds: G:T.68, G:F.70, G:F.70, G:N.76, G:N.76, C:I.186
- Water bridges: G:F.69, G:F.69
- 2 x CDL: CARDIOLIPIN(Non-covalent)
CDL.41: 24 residues within 4Å:- Chain C: T.46, M.49, L.50, M.52, Y.53, W.56, R.57, I.60, R.61, F.65, V.169, T.172, S.210, T.211, I.214, V.215, F.218, R.219, K.222, H.224
- Chain J: K.8, F.12, L.31
- Ligands: EDO.47
23 PLIP interactions:20 interactions with chain C, 3 interactions with chain J- Hydrophobic interactions: C:T.46, C:M.49, C:L.50, C:Y.53, C:Y.53, C:Y.53, C:Y.53, C:W.56, C:W.56, C:V.169, C:T.172, C:I.214, C:I.214, C:F.218, J:L.31
- Hydrogen bonds: C:Y.53
- Water bridges: C:R.61, J:K.8, J:G.24
- Salt bridges: C:R.61, C:K.222, C:K.222, C:H.224
CDL.64: 16 residues within 4Å:- Chain C: N.123, L.125, L.129, L.136, V.140, Y.251, V.252
- Chain G: L.23, S.27, L.30, C.31, N.34, L.37, H.38
- Ligands: PEK.38, EDO.49
13 PLIP interactions:7 interactions with chain C, 6 interactions with chain G- Hydrophobic interactions: C:L.129, C:L.136, C:L.136, C:V.140, C:Y.251, C:V.252, G:L.23, G:L.30, G:L.37
- Hydrogen bonds: C:N.123, G:N.34, G:N.34, G:H.38
- 8 x DMU: DECYL-BETA-D-MALTOPYRANOSIDE(Non-covalent)(Non-functional Binders)
DMU.51: 11 residues within 4Å:- Chain C: M.31, N.36, S.37, T.39, I.43
- Chain J: T.37, L.38, G.41, G.42, Y.45
- Ligands: DMU.70
8 PLIP interactions:3 interactions with chain J, 5 interactions with chain C- Hydrophobic interactions: J:L.38, J:Y.45, J:Y.45, C:I.43
- Hydrogen bonds: C:N.36, C:S.37, C:S.37
- Water bridges: C:M.38
DMU.67: 7 residues within 4Å:- Chain C: L.29, W.32, M.38
- Chain G: S.61, W.62, G.63
- Ligands: PEK.63
4 PLIP interactions:2 interactions with chain C, 2 interactions with chain G- Hydrophobic interactions: C:L.29, C:W.32
- Hydrogen bonds:
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.65 Å
- Oligo State
- hetero-1-1-1-1-1-1-1-1-1-1-1-1-1-mer
- Ligands
- 2 x HEA: HEME-A(Non-covalent)
- 1 x CU: COPPER (II) ION(Non-covalent)
- 1 x MG: MAGNESIUM ION(Non-covalent)
- 1 x NA: SODIUM ION(Non-functional Binders)
- 1 x CYN: CYANIDE ION(Non-covalent)
- 3 x TGL: TRISTEAROYLGLYCEROL(Non-covalent)
- 4 x PGV: (1R)-2-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PALMITOYLOXY)METHYL]ETHYL (11E)-OCTADEC-11-ENOATE(Non-covalent)
- 48 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 1 x CUA: DINUCLEAR COPPER ION(Non-covalent)
- 1 x PSC: (7R,17E,20E)-4-HYDROXY-N,N,N-TRIMETHYL-9-OXO-7-[(PALMITOYLOXY)METHYL]-3,5,8-TRIOXA-4-PHOSPHAHEXACOSA-17,20-DIEN-1-AMINIUM 4-OXIDE(Non-covalent)
- 5 x CHD: CHOLIC ACID(Non-covalent)
- 2 x PEK: (1S)-2-{[(2-AMINOETHOXY)(HYDROXY)PHOSPHORYL]OXY}-1-[(STEAROYLOXY)METHYL]ETHYL (5E,8E,11E,14E)-ICOSA-5,8,11,14-TETRAENOATE(Non-covalent)
- 2 x CDL: CARDIOLIPIN(Non-covalent)
- 8 x DMU: DECYL-BETA-D-MALTOPYRANOSIDE(Non-covalent)(Non-functional Binders)